BridgeMD
New treatment option for Pain
Official title Evaluation of an Opioid Stewardship Program in Non-Cancer Patients
ClinicalTrials.gov ID: NCT07102446
What this study is testing
- What it's testing
- The objective of this prospective, non-randomized clinical trial is to evaluate the effectiveness of a pharmacist-led Opioid Stewardship Program (OSP) in outpatient adults with chronic non-cancer pain. This study compared OSP implementation with a historical control to determine whether it reduces the incidence of high-risk opioid prescribing and improves patients' awareness, knowledge, and attitudes about opioid use.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 79
You may be able to join if
- Outpatients at the Department of Anesthesiology and Pain Medicine or the Department of Physical Medicine \& Rehabilitation of the study site who...
- Adults aged ≥19 years and \<80 years
- Patients who voluntarily signed a written informed consent form after receiving a full explanation of the study and understanding its purpose
You likely can't join if
- Patients with active cancer
- Patients diagnosed with sickle cell disease
- Patients diagnosed with a life-limiting illness eligible for hospice or palliative care as defined in Article 2 of the 'ACT ON HOSPICE AND PALLIATIVE...
- Pregnant patients
- Patients who were prescribed opioid analgesics within the past month for postoperative pain management
- Patients who were prescribed opioid analgesics within the past month for newly developed pain
See the full eligibility criteria
- Outpatients at the Department of Anesthesiology and Pain Medicine or the Department of Physical Medicine \& Rehabilitation of the study site who received a prescription for opioid analgesics (oral, transdermal...
- Adults aged ≥19 years and \<80 years
- Patients who voluntarily signed a written informed consent form after receiving a full explanation of the study and understanding its purpose
- Patients with active cancer
- Patients diagnosed with sickle cell disease
- Patients diagnosed with a life-limiting illness eligible for hospice or palliative care as defined in Article 2 of the 'ACT ON HOSPICE AND PALLIATIVE CARE AND DECISIONS ON LIFE-SUSTAINING TREATMENT FOR PATIENTS AT THE...
- Pregnant patients
- Patients who were prescribed opioid analgesics within the past month for postoperative pain management
- Patients who were prescribed opioid analgesics within the past month for newly developed pain
- Patients with communication difficulties
- Patients who were prescribed buprenorphine for the treatment of opioid use disorder
- Patients who are deemed inappropriate for study participation at the discretion of the investigator
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years to 79 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.